Transcatheter versus surgical aortic valve replacement in patients with end stage renal disease.
Muhammad Usman KhanMuhammad Zia KhanAnkur KalraTroy KrupicaEdo KaluskiSafi U KhanPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
Among patients with AS and ESRD, despite providing therapy to subjects with higher comorbidity burden, TAVR was associated with lower inpatient mortality, complications, length of stay, cost of care, and higher home disposition rates when compared with SAVR.
Keyphrases
- end stage renal disease
- aortic valve replacement
- chronic kidney disease
- aortic stenosis
- aortic valve
- peritoneal dialysis
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- palliative care
- healthcare
- risk factors
- ejection fraction
- left ventricular
- cardiovascular events
- coronary artery disease
- quality improvement
- pain management
- cardiovascular disease
- bone marrow
- affordable care act
- health insurance